Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above

NCT05815264 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Pneumonia

Interventions

BIOLOGICAL: 23-valent pneumococcal polysaccharide vaccine
BIOLOGICAL: pneumococcal vaccine polyvalent

Sponsor

Ab&B Bio-tech Co., Ltd.JS

Collaborators

[object Object]